Guangdong Provincial Market Supervision Bureau helps epidemic-related drugs and medical supplies companies quickly obtain patent rights-Industry News-Shenzhen deep trust patent Agency Co., LTD

News Updates

NEWS CENTER

Related News

There is currently no data available

Home

Guangdong Provincial Market Supervision Bureau helps epidemic-related drugs and medical supplies companies quickly obtain patent rights

Release Time：

2023-02-27

The first is to respond quickly to improve the efficiency of patent application review services for epidemic-related drugs and medical supplies companies. The second is precise docking to protect the innovation and development of key medical supplies companies. The third is to improve the special patent database and provide patent information resource support for epidemic-related drugs and medical supplies companies.

In order to maintain market price order, quickly and seriously investigate and deal with illegal activities such as price gouging, hoarding, false publicity, false illegal advertising, counterfeiting and shoddy behavior that have strong social response, ensure product quality, and ensure that the people purchase medicines at a guaranteed price and the quality of medicines is guaranteed. Legitimate rights and interests are protected.

The Guangdong Market Supervision has specially launched the #Stabilize Price and Guarantee Quality Action column in order to better safeguard the vital interests of the people and serve the overall economic and social development.

As the Guangdong Provincial Administration for Market Regulation continues to promote the implementation of special actions to stabilize prices and quality of epidemic-related drugs and medical supplies, it continues to optimize working mechanisms, improve service efficiency, strengthen precise docking, and provide relevant entities with epidemic-related drugs and medical supplies in Guangdong. Efficient, convenient and high-quality intellectual property related services fully support the rapid acquisition of corporate patent rights and promote corporate innovation and development.

The first is to respond quickly to improve the efficiency of patent application review services for epidemic-related drugs and medical supplies companies.

Establish a green channel for pre-examination of patents related to epidemic prevention and control. A notice of acceptance or rejection will be issued on the same day that an application for an epidemic prevention-related patent is accepted. If the application meets the acceptance conditions, a pre-examination conclusion will be issued within 2 working days. Optimize the priority review and recommendation process for patent applications related to epidemic-related drugs and medical supplies, and complete the priority review and recommendation process for relevant patent applications within 1 working day. Since the launch of the special action, the patent pre-examination green channel has accepted a total of 5 patents related to epidemic prevention and control from 3 innovative entities, 3 of which have entered the fast review channel; 6 patent applications have been recommended to the State Intellectual Property Office for priority review to help qualified patent applications as soon as possible Authorized.

The second is precise docking to protect the innovation and development of key medical supplies companies.

Coordinate and resolve intellectual property issues existing in the production process of my country's first set of ECMO (extracorporeal membrane oxygenation system) equipment. We immediately contacted Shenzhen Hannuo Medical Technology Co., Ltd. and went to the company to conduct on-site research to understand the company's intellectual property needs. Focusing on the company's specific ECMO focus areas, we carried out patent analysis related to the distal perfusion cannula (DPC) structure to help companies clarify R&D and market trends and avoid patent risks. Guide enterprises to make full use of the rapid pre-examination channel for patents and the priority review channel for patent applications in the Shenzhen Agency to speed up patent acquisition and strengthen the intellectual property reserve and protection of ECMO products.

The third is to improve the special patent database and provide patent information resource support for epidemic-related drugs and medical supplies companies.

Establish a special database of patent information on epidemic-related drugs and medical supplies, collecting more than 21,500 patents covering 7 secondary branches and 18 tertiary branches such as diagnosis and testing, antiviral drugs, medical respiratory protection, environmental disinfection and waste treatment, etc. files, free and open to the public. Establish a patent database for the biomedicine and health industry, including 7 first-level navigation nodes for biological medicines, chemical medicines, modern traditional Chinese medicines, high-end medical devices, core key technologies, biomanufacturing, and modern health services, with a total of more than 4 million patents, broadening the horizons for enterprises scientific research ideas, reduce R&D costs and provide patent information support.

Next, the Guangdong Provincial Market Supervision Bureau will strengthen the omni-channel publicity of patent pre-examination, priority examination and special patent database for epidemic-related drugs and medical supplies companies, strengthen the tracking services of pre-examination qualified cases and priority examination cases, further improve examination efficiency, and tap Enterprise patent technology needs, promote technology and product content innovation in industries related to epidemic-related drugs and medical supplies, and guide more companies to make full use of the fast track to accelerate patent layout.

More intellectual property information and services

Follow the official subscription account of [Shenxin Intellectual Property] on the code

Follow the official service account of [Shentrust Intellectual Property Service Platform] on the code